BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum

Date:


BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum BioMark Comprehensive Metabolomics Assay Selected asTop Canadian Innovation for the CTS Beaver Den Innovation Award VANCOUVER, BRITISH COLUMBIA – (April 14, 2026) – BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF), a leading developer of liquid […]

The post BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum appeared first on Biomark Diagnostics.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

What Works (and What Doesn’t) for Canadian Advocacy Campaigns in the AI Era

Ever since Canadians ubiquitously adopted smartphones, the digital...

Liberals leading among Trekkies, Swifties, and Tim Hortons voters

November 17, 2026 — A large sample survey...

Regulatory review models and approval timelines across African regulators – Chisha 2026

A new study involving CIRS compares regulatory review...